Key result
Thromboprophylaxis with low molecular weight heparin and low-dose aspirin during pregnancy reduces the risk of thrombosis and adverse outcomes in women with inherited thrombophilia, whereas evidence for nattokinase remains limited.
Why the study?
Pulmonary embolism remains the leading cause of maternal mortality despite increasing LMWH use, but evidence for optimal thromboprophylaxis to prevent VTE and pregnancy complications in women with thrombophilia is scarce.
Does thromboprophylaxis (LMWH, aspirin, nattokinase) prevent adverse complications in pregnant women with inherited thrombophilia?
Does thromboprophylaxis (LMWH, aspirin, nattokinase) prevent adverse complications in pregnant women with inherited thrombophilia?
LMWH and aspirin are established prophylactic strategies to reduce VTE and adverse pregnancy outcomes in women with inherited thrombophilia, whereas alternative therapies like nattokinase lack sufficient evidence.
Answers are grounded in this paper and cite their sources.
Scarce evidence on thromboprophylaxis leaves optimal strategies undefined in high-risk pregnancies; prospective trials needed before practice change.
Compared with non-pregnant women, pregnancy alone carries a three- to fivefold higher risk of venous thromboembolism (VTE). Despite the increasing use of low-molecular-weight heparin in identified high-risk patients, pulmonary embolism is still the leading cause of maternal mortality. However, evidence for optimal use of thromboprophylaxis is scarce. Thrombophilia (hereditary or acquired) is thought to predispose to both VTE and is also associated with complications of pregnancy, such as recurrent miscarriages and preeclampsia. This review discusses the current evidence for optimal thromboprophylaxis during pregnancy by focusing primarily on VTE prevention strategies, the potential to prevent recurrent complications during pregnancy with low molecular weight heparin (LMWH), aspirin, and Nattokinase in pregnant women with congenital thrombophilia.
No takes yet. Share an insight, caveat, or question.
Kirovakov et al. (2024) conducted a review in Inherited thrombophilia in pregnancy. Thromboprophylaxis (Low Molecular Weight Heparin, Aspirin, Nattokinase) was evaluated. Thromboprophylaxis with low molecular weight heparin and low-dose aspirin during pregnancy reduces the risk of thrombosis and adverse outcomes in women with inherited thrombophilia, whereas evidence for nattokinase remains limited.
Synapse has enriched 10 related papers. Consider them for comparative context: